Document is current
Any future updates will be listed below
-
Authors
Kiyooka, Takahiko
Ohanyan, Vahagn
Yin, Liya
Pung, Yuh Fen
Chen, Yeong-Renn
Chen, Chwen-Lih
Kang, Patrick T.
Hardwick, James P.
Yun, June
Janota, Danielle
Peng, Joanna
Kolz, Christopher
Guarini, Giacinta
Wilson, Glenn
Shokolenko, Inna
Stevens, Donte A.
Chilian, William M. http://orcid.org/0000-0003-4522-7914
-
Funding
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (HL135024, HL135110, HL135110, HL137008, HL142710)
Fibus Family Foundation
Schermer Family Trust
- License Information
-
More Information
Article History
Received: 7 July 2020
Revised: 21 December 2021
Accepted: 22 December 2021
First Online: 17 January 2022
Declarations
:
: Dr. Wilson has an interest in Exscien, which supplied the recombinant proteins, mt-tat-EndoIII and mt-tat-ExoIII. There are no other disclosures or conflicts of interest.
: All animal experiments were approved by the Institutional Animal Care and Use Committee. The manuscript does not contain clinical studies or patient data.
: All the authors consent to publication and approve of this version of the paper.
